Evidence map›Paper›PMID 34494853›Full record

ArticleMicrobiology spectrum2021

Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.

Hyeon-Ji Hwang, Heejeong Choi, Sojeong Hong, Hyung Ryong Moon, Joon-Hee Lee

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  4. Article
  5. Machine learning for predictingBioinformation · 2025
    Article
  6. Article
  7. Review
  8. Virulence Factors ofFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hyeon-Ji HwangDepartment of Pharmacy, College of Pharmacy, Pusan National Universitygrid.262229.f, Busan, South Korea.
Heejeong ChoiDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National Universitygrid.262229.f, Busan, South Korea.
Sojeong HongDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National Universitygrid.262229.f, Busan, South Korea.
Hyung Ryong MoonDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National Universitygrid.262229.f, Busan, South Korea.
Joon-Hee LeeDepartment of Pharmacy, College of Pharmacy, Pusan National Universitygrid.262229.f, Busan, South Korea.ORCID 0000-0003-4290-2945
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa, a human pathogen, causes both acute and chronic infections that are mediated by virulence factor production and biofilm formation. Since both characteristics of P. aeruginosa are regulated by quorum sensing (QS), we screened 126 synthetic chemicals for anti-QS activity and finally selected the compounds that have both antivirulence and antibiofilm activities. To efficiently screen the chemical library, the following reporter-based bioassay systems were used: the QS- or biofilm-specific promoter-

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsDrug Evaluation, PreclinicalPseudomonas aeruginosaPseudomonas InfectionsQuorum SensingTenebrioVirulenceVirulence FactorsAnti-Bacterial AgentsVirulence Factorsantibiofilmantipathogenic compoundantivirulencebiofilmchemical screeningPseudomonas aeruginosaquorum sensingvirulence

Identifiers

PMID34494853
PMCPMC8557914
OpenAlexW3198002251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.